Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Masakazu Ogura"'
Autor:
Tatsuya Suwa, Yuichi Ishida, Yoshiharu Negoro, Fusako Kusumi, Yoshio Kadokawa, Rihito Aizawa, Toshifumi Nakajima, Yoshiaki Okamoto, Yoshishige Okuno, Kazunari Yamada, Masakazu Ogura, Masao Murakami, Takashi Mizowaki
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss , Pp 88-94 (2021)
Background and purpose: To assess the long-term outcomes of a multimodal approach for maximum esophagus preservation in operable patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma (ESCC). Materials and metho
Externí odkaz:
https://doaj.org/article/dd829ddd57e14cbcb9a120ba43066e09
Autor:
Lisa Jane Mackenzie, Mariko Leanne Carey, Eiji Suzuki, Robert William Sanson-Fisher, Hiromi Asada, Masakazu Ogura, Catherine D'Este, Michio Yoshimura, Masakazu Toi
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198437 (2018)
This study assessed agreement between radiation oncologist- and cancer patient-reported perceptions about cancer diagnosis, time since diagnosis, treatment purpose, and whether life expectancy had been discussed; and described preferences for prognos
Externí odkaz:
https://doaj.org/article/4cbe3047ef1941e3a5ab2e090ce501e8
Autor:
Noriko, Kishi, Yukinori, Matsuo, Takashi, Shintani, Masakazu, Ogura, Takamasa, Mitsuyoshi, Norio, Araki, Kota, Fujii, Setsuko, Okumura, Kiyoshi, Nakamatsu, Takahiro, Kishi, Tomoko, Atsuta, Takashi, Sakamoto, Shuji, Ohtsu, Tomohiro, Katagiri, Masaru, Narabayashi, Satsuki, Fujishiro, Yusuke, Iizuka, Hiroaki, Ozasa, Toyohiro, Hirai, Takashi, Mizowaki
Publikováno v:
Journal of Radiation Research. 64:142-153
Chemoradiotherapy followed by consolidation durvalumab (CCRT+D) improves survival in patients with stage III non-small-cell lung cancer (NSCLC). We compared recurrence patterns and survival in the CCRT+D and CCRT cohorts. We conducted a multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8e2c7d35d3c7813f9b81dec7169867
https://doi.org/10.1093/jrr/rrac057
https://doi.org/10.1093/jrr/rrac057
Autor:
Masakazu Ogura, Tatsuya Suwa, Masao Murakami, Yoshishige Okuno, Yoshiharu Negoro, Toshifumi Nakajima, Yoshiaki Okamoto, Yuichi Ishida, Kazunari Yamada, Yoshio Kadokawa, Takashi Mizowaki, Rihito Aizawa, Fusako Kusumi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss, Pp 88-94 (2021)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Endoscopically unresectable stage I esophageal cancer is usually treated by surgery. • Operable stage I esophageal carcinomas were treated with our multimodal approach. • Based on interim appraisal, most patients were treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ca58740f0ec2be87deade8542147dd
http://www.sciencedirect.com/science/article/pii/S2405630821000719
http://www.sciencedirect.com/science/article/pii/S2405630821000719
Autor:
Yusuke Kawanaka, Yuto Yasuda, Junko Tanizaki, Daisuke Iwashima, Yoshikane Nonagase, Kiyoshi Uemasu, Yutaka Hirayama, Masakazu Ogura, Tomohiro Ozaki, Ken-ichi Takahashi
Publikováno v:
Respiratory investigation. 60(5)
Some lung cancer patients have preexisting interstitial lung disease (ILD), which is considered a risk factor for lung cancer treatment. This study investigated the safety and efficacy of durvalumab consolidation therapy for patients with stage III n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::730c3f219d500fbda58d226dd468c656
https://pubmed.ncbi.nlm.nih.gov/35725721
https://pubmed.ncbi.nlm.nih.gov/35725721
Autor:
M. Sakamoto, Takamasa Mitsuyoshi, Tomoko Atsuta, Norio Araki, Yukinori Matsuo, Takashi Sakamoto, Takashi Shintani, Tomohiro Katagiri, Yuichi Ishida, Setsuko Okumura, Kiyoshi Nakamatsu, Satsuki Fujishiro, Young Hak Kim, Takashi Mizowaki, Noriko Kishi, Kota Fujii, Masaru Narabayashi, Masakazu Ogura, Takahiro Kishi
Publikováno v:
Clinical lung cancer. 22(5)
Introduction Data on the risk factors for symptomatic radiation pneumonitis (RP) in non–small-cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) and consolidation durvalumab are limited; we aimed to investigate these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccd3f2b86209a4ba7fc8277f51bc980
https://pubmed.ncbi.nlm.nih.gov/33678582
https://pubmed.ncbi.nlm.nih.gov/33678582
Autor:
Ryo Kakino, Takamasa Mitsuyoshi, Masakazu Ogura, Norio Araki, Chikako Yamauchi, Takanori Adachi, Shuji Otsu, Yukinori Matsuo, Masaki Kokubo, Hideaki Hirashima, Satoshi Itasaka, Mitsuhiro Nakamura, Takashi Mizowaki, Yoshiharu Negoro, Takashi Sakamoto, Masato Fushiki, Takashi Shintani, M. Sakamoto
Publikováno v:
Medical physicsReferences. 47(9)
PURPOSE To predict local recurrence (LR) and distant metastasis (DM) in early stage non-small cell lung cancer (NSCLC) patients after stereotactic body radiotherapy (SBRT) in multiple institutions using breath-hold computed tomography (CT)-based radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ca3708186916464708e54212f12e32
https://pubmed.ncbi.nlm.nih.gov/32645224
https://pubmed.ncbi.nlm.nih.gov/32645224
Autor:
Michio Yoshimura, Masahiro Hiraoka, Masahiro Takada, Masakazu Toi, Megumi Takeuchi, Kimiko Hirata, Minoru Inoue, Masakazu Ogura, Eiji Suzuki, Chikako Yamauchi
Publikováno v:
Journal of Radiation Research
Radiotherapy with breast-conserving therapy plays a crucial role in the treatment of early breast cancer. However, optimal radiotherapy targets have been controversial. We therefore evaluated regional recurrence in breast cancer patients with one to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f5a26c93849d2791a02c014c90e35a
https://doi.org/10.1093/jrr/rrw071
https://doi.org/10.1093/jrr/rrw071
Autor:
Keita Kudo, Kaoru Tanaka, Tomohiro Ozaki, Yosuke Tamura, Yoshikazu Hasegawa, Yasuhito Fujisaka, Hidetoshi Hayashi, Junko Tanizaki, Yasutaka Chiba, Hiroshige Yoshioka, Masakazu Ogura, Kazuhiko Nakagawa, Takashi Niwa, Takayasu Kurata, Toshihide Yokoyama
Publikováno v:
Oncologist
Lessons Learned The combination of cisplatin plus nab-paclitaxel with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer is a promising therapeutic strategy. Further investigation is warranted. Background We conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c340d66f7e552f203528be12a6e535e
https://doi.org/10.1002/onco.13524
https://doi.org/10.1002/onco.13524
Autor:
Sayaka Sato, Michio Yoshimura, Masakazu Ogura, Mitsuhiro Nakamura, Takahiro Fujimoto, Kimiko Hirata, Masahiro Yamada, Makoto Sasaki, Minoru Inoue, Masahiro Hiraoka
Publikováno v:
Medical Physics. 42:1904-1910
Purpose: To investigate image-registration errors when using fiducial markers with a manual method and the point-based rigid-body registration (PRBR) algorithm in accelerated partial breast irradiation (APBI) patients, with accompanying fiducial devi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2be071deb5ca53d934bdf562177086b6
https://doi.org/10.1118/1.4915534
https://doi.org/10.1118/1.4915534